ATLASATLAS fair value
ATLAS has no fair value for this stock today.
The Biotech Growth Trust (BIOG.LSE)
The Biotech Growth Trust share price today, ATLAS forecast and fair value
Financial Services · Asset Management · London Stock Exchange · United Kingdom
£13.72▲ +2.69%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on The Biotech Growth Trust in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On The Biotech Growth Trust
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives The Biotech Growth Trust a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £13.13 and £14.41; in 9 out of 10, between £12.09 and £15.66. Estimated annual volatility is 28%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- £253M
- Market cap (USD)
- $337M
- P/E ratio
- 2.4
- 52-week high
- £17.86
- 52-week low
- £10.54
- Revenue (12 months)
- £135M
- Operating margin
- 97.5%
- Net margin
- 96.5%
- Beta
- 0.29
What this means
ATLAS does not publish a fair value for BIOG.LSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BIOG.LSE has traded between £10.54 and £17.86. Today it is 23.2% below that high and 30% above its low.
On the business: net margin is 96.5%; it trades at 2.4 times earnings.
Its beta is 0.29: it tends to move less than the market.
About the company
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector.
Want to see everything about The Biotech Growth Trust?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does The Biotech Growth Trust do?
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector.
What is the chance BIOG.LSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, BIOG.LSE ends the month between £13.13 and £14.41.
How big is The Biotech Growth Trust and what is its P/E ratio?
The Biotech Growth Trust's market capitalization is £253M. Its price-to-earnings (P/E) ratio is 2.4: you pay £2.42 for each £1.00 of yearly earnings.
How volatile is BIOG.LSE?
ATLAS estimates annual volatility at 28%. In a typical month, half of the outcomes end between £13.13 and £14.41.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer